Number of the records: 1
antigén CA-19-9
SYS d018395 LBL 00000cx--j2200000---45-- 005 20240119200224.8 100 $a 19940416asloy0103----ba0 152 $b mesh 250 $a antigén CA-19-9 $x AD $x AE $x AN $x BI $x BL $x CF $x CH $x CL $x DE $x EC $x GE $x HI $x IM $x IP $x ME $x PD $x PH $x PO $x RE $x TO $x TU $x UL $x UR $8 slo 300 1-
$a 1995; was see ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE 1989-1994; for Sialyl Lewis A use OLIGOSACCHARIDES 1994-2019 $8 eng 300 1-
$a Antigens, Neoplasm (1984-1988) $8 eng 300 1-
$a Antigens, Tumor-Associated, Carbohydrate (1989-1994) $8 eng 330 1-
$a Sialylated Lewis(a) blood group carbohydrate antigen found in many adenocarcinomas of the digestive tract, especially pancreatic tumors. $8 eng 450 $a 5-Acetylneuraminyl-2-3-Galactosyl-1-3-(Fucopyranosyl-1-4)-N-Acetylglucosamine $5 e $8 eng 450 $a Antigen CA-19-9 $5 e $8 eng 450 $a Gastrointestinal Cancer Antigen $5 e $8 eng 450 $a Sialyl Le(a) $5 e $8 eng 450 $a Sialyl Lewis A $5 e $8 eng 450 $a Sialyl Lewis A Antigen $5 e $8 eng 450 $a Sialyl Lewis(a) Tetrasaccharide $5 e $8 eng 450 $a 5-acetylneuraminyl-2-3-galaktozyl-1-3-(fukopyranozyl-1-4)-N-acetylglukózamín $5 e $8 slo 450 $a CA-19-9 antigén $5 e $8 slo 450 $a antigén nádorový gastrointestinálny $5 e $8 slo 450 $a NAG-1,3-F-1,4-GN $5 e $8 slo 450 $a Neu5Ac-2-3-Gal-1-3-(Fuc-1-4)-GlcNAc $5 e $8 slo 450 $a Sialyl Le(a) $5 e $8 slo 450 $a sialyl Lewis A $5 e $8 slo 450 $a sialyl Lewis A antigén $5 e $8 slo 450 $a sialyl Lewis(a) tetrasacharid $5 e $8 slo 450 $a alfa-Neu5Ac-(2-3)-beta-D-Gal-(1-3)-(alfa-L-Fuc-(1-4))-beta-D-GlcNAc $5 e $8 slo 686 $a D23.050.285.050.119 686 $a D23.050.301.290.544.119 686 $a D23.050.550.325.119 686 $a D23.050.705.230.544.119 686 $a D23.101.140.075.119 750 $a CA-19-9 Antigen $8 eng 801 -0
$a US $b DNLM $c 19940416 801 -2
$a SK $b BA006 $c 19990812 801 -2
$a SK $b BA006 $c 20201013 980 $x M
Number of the records: 1